. In addition, the early Seder et al., 1993; Abbas et al., 1996; Fearon macrophage proinflammatory cytokines by Trypanoand Locksley, 1996). During infection with T.cruzi, the soma cruzi is considered to be important in controlling induction of parasite-specific CMI is likely to be involved the infection and the outcome of Chagas' disease. Here in at least two aspects of Chagas' disease pathophysiology we show that the potent tumour necrosis factor-α-, (Vespa et al., 1994; Fearon and Locksley, 1996 ; Brener interleukin-12-and nitric oxide-inducing activities of and Gazzinelli, 1997). The first is the control of parasite T.cruzi trypomastigote mucins were recovered quantireplication and its spread in the vertebrate host tissues. tatively in a highly purified and characterized glycosyl-
stimulation of macrophages and natural killer (NK) cells appears to have an important role in directing the developIntracellular protozoan parasites are potent stimulament of cell-mediated immunity (CMI) (Hsieh et al., tors of cell-mediated immunity. The induction of
1993; Seder et al., 1993; Abbas et al., 1996 ; Fearon macrophage proinflammatory cytokines by Trypanoand Locksley, 1996) . During infection with T.cruzi, the soma cruzi is considered to be important in controlling induction of parasite-specific CMI is likely to be involved the infection and the outcome of Chagas' disease. Here in at least two aspects of Chagas' disease pathophysiology we show that the potent tumour necrosis factor-α-, (Vespa et al., 1994; Fearon and Locksley, 1996 ; Brener interleukin-12-and nitric oxide-inducing activities of and Gazzinelli, 1997) . The first is the control of parasite T.cruzi trypomastigote mucins were recovered quantireplication and its spread in the vertebrate host tissues. tatively in a highly purified and characterized glycosyl-
The second is the inflammatory reaction observed in the phosphatidylinositol (GPI) anchor fraction of this infected host tissues, which is likely to be a major cause material. The bioactive trypomastigote GPI fraction of cardiac tissue damage during the acute and chronic was compared with a relatively inactive GPI fraction phases of the disease. prepared from T.cruzi epimastigote mucins. The trypoRelatively little is known about the protozoan parasite mastigote GPI structures were found to contain addimolecules that initiate the synthesis of pro-inflammatory tional galactose residues and unsaturated, instead of cytokines and nitric oxide (NO) by macrophages. Recent saturated, fatty acids in the sn-2 position of the alkylstudies have suggested a role for glycosylphosphatidylacylglycerolipid component. The latter feature is esseninositol (GPI) anchors from Plasmodium falciparum tial for the extreme potency of the trypomastigote (Schofield and Hackett, 1993; Schofield et al., 1996 ; GPI fraction, which is at least as active as bacterial Tachado et al., 1996 Tachado et al., , 1997 and Trypanosoma brucei endotoxin and Mycoplasma lipopeptide and, therefore, (Magez et al., 1998) in this process. However, no evidence one of the most potent microbial proinflammatory of the biochemical purity of the P.falciparum GPIs was agents known.
provided, making estimates of their concentrations dubiKeywords: Chagas' disease/cytokines/glycosylphosphaous. Furthermore, the possibility of Mycoplasma lipopeptidylinositol/inflammation/nitric oxide tide (Mühlradt et al., 1997) contamination (that has confounded other studies into proinflammatory factors) cannot be formally excluded. In the case of the T.brucei GPI work, highly purified and structurally characterized Introduction fractions were used, but cytokine induction was only seen when these molecules were used at micromolar The protozoan parasite Trypanosoma cruzi is transmitted concentrations that may not be physiologically relevant. to mammals in the faeces of the reduviid bug insect vector.
We have described previously the ability of GPIThe metacyclic trypomastigotes that enter the mammalian anchored mucin-like glycoproteins from the trypohost, via skin lesions and/or mucous membranes, invade mastigote (but not the epimastigote or metacyclic) life host cells and differentiate into small amastigote forms cycle stage of T.cruzi to trigger the synthesis of tumour that replicate in the cytoplasm. Following differentiation necrosis factor (TNF)-α, IL-12 and NO by mouse inflaminto non-dividing bloodstream form trypomastigotes, the parasites escape and re-invade host cells (predominantly matory macrophages (Camargo et al., 1997a,b) . The Octyl-Sepharose chromatograms of T.cruzi trypomastigote (A) and epimastigote (B) glycoconjugate extracts from 1.5 ϫ 10 10 and 2.0 ϫ 10 10 cells, respectively. Aliquots of each fraction were presented to 10 6 thioglycollate-elicited, IFN-γ-primed, murine peritoneal macrophages and the amounts of TNF-α (d), IL-12(p40) (s) and NO (u) (measured as nitrite) produced in 24 h were measured. Vertical bars indicate the molarity of the glycoconjugate used in each assay, based on the myo-inositol content of each fraction eluted from the column. The data shown in (A) and (B) are representative of three different fractionation experiments. Peak fractions were pooled as indicated and titrated for TNF-α-(C), IL-12(p40)-(D) and NO-(E) inducing activity. Trypomastigote-derived peak I and II materials (d, s); epimastigote-derived peak I, II and III materials (u, m, n) . The data shown in (C-E) are representative of three separate titration experiments with three different sets of fractions. Each cytokine and NO determination was carried out in duplicate, and the error bars (where visible) indicate the standard error of the mean.
present study was undertaken to isolate and define the Essentially all of the cytokine-and NO-inducing activity of the trypomastigote preparation co-eluted with a peak active component(s) of the T.cruzi trypomastigote mucins, establish their purity and structure, compare their structure of myo-inositol-containing material ( Figure 1A , peak II). Another earlier eluting peak containing myo-inositol was with similar yet relatively inactive material for T.cruzi epimastigote and metacyclic forms, look directly for also observed ( Figure 1A , peak I), but this material had little or no NO-or cytokine-inducing activity. The possible Mycoplasma lipopeptide contamination and establish their potency in precise molar terms. A detailed equivalent preparation from epimastigotes produced three myo-inositol-containing peaks (peaks I-III) that had little knowledge of the structure-activity relationships of parasite cytokine-inducing factors may provide insights into or no cytokine-or NO-inducing activity ( Figure 1B ). The epimastigote peak III material was analysed by the processes controlling the inflammatory responses responsible for the immunopathology associated with electrospray-mass spectrometry (ES-MS) (data not shown) and found to contain the previously described GPI-related many protozoan parasite infections.
glycoinositol phospholipids (GIPLs) (De Lederkremer et al., 1976 Mendonça-Previato et al., 1983;  Results Previato et al., 1990; Carreira et al., 1996) that are much Purification and analysis of T.cruzi trypomastigote less abundant in trypomastigotes (Golgher et al., 1993) .
and epimastigote mucins
The peak I and peak II fractions from the trypomastigote We purified trypomastigote and epimastigote mucins from and epimastigote preparations were analysed by SDS-Y strain T.cruzi as described before (Almeida et al., 1994;  PAGE and silver staining (not shown), which revealed the Serrano et al., 1995) and analysed the fractions eluting characteristic high and low apparent molecular weight from the final octyl-Sepharose chromatography step for mucins of these life cycle stages, respectively (Alves and myo-inositol content, by selected ion-monitoring gas chroColli, 1975; Previato et al., 1985; Schenkman et al., matography-mass spectrometry (GC-MS) Almeida et al., 1994; Camargo et al., 1997a) . The 1993), and for the induction of TNF-α, IL-12 and NO trypomastigote peak I and II fractions also reacted strongly when presented to interferon (IFN)-γ-primed C3H/HeJ with total serum and anti-α-galactosyl antibodies isolated from patients with chronic Chagas' disease (Almeida mouse macrophages (Camargo, 1997a,b) (Figure 1 ). et al., 1991) , which is synonymous with the presence of trypomastigote peak II mucins (Figure 2A -C). The purified trypomastigote GPI anchors had essentially the same trypomastigote mucins (Almeida et al., 1994) .
The phosphatidylinositol (PI) moieties of the GPI anchors specific activity (relative to myo-inositol content) as the intact trypomastigote peak II mucins and, as expected, the of the purified trypomastigote and epimastigote mucins (peaks I and II) and the epimastigote GIPLs (peak III) purified epimastigote GPI anchors had relatively little activity. The purified GPI anchors were analysed by were released by nitrous acid deamination and analysed by ES-MS and ES-MS-collision-induced dissociation ES-MS ( Figure 2D and E). Both preparations showed ion clusters corresponding to doubly charged pseudomolecular (CID)-MS (Table I) . These data were consistent with those previously published for the epimastigote mucins (Previato ions. In the case of the epimastigote mucin GPI anchors, the m/z values of these ions can be interpreted readily in et Serrano et al., 1995) and GIPLs (Previato et al., 1990; De Lederkremer et al., 1991 Carreira et al., terms of the known primary structures and compositions of these GPI anchors (Figures 2E and 5) (Previato et al., 1996) and trypomastigote mucins , and further showed that the peak I fractions contained 1995; Serrano et al., 1995) . Taking into account these assignments, and the data on the PI molecular species in mainly lyso-PI species.
The trypomastigote and epimastigote peak materials Table I , the doubly charged ions of the trypomastigote GPI anchors can also be interpreted (Figures 2D and 5) . from Figure 1 were pooled separately, quantified by total myo-inositol content and, using these values to estimate
In essence, the epimastigote anchors contain 4-5 hexoses and fully saturated alkylacyl-PI moieties, whereas the the molarity of the fractions, titrated for the induction of TNF-α, IL-12 and NO when presented to macrophages trypomastigote anchors contain 4-8 hexoses and mainly unsaturated (C18:1 or C18:2) fatty acids in their ( Figure 1C -E). The trypomastigote peak II material was extremely active, giving significant induction of TNF-α alkylacyl-PI moieties. The precise arrangement of the hexoses in the trypomastigote mucins was not determined, and IL-12 at concentrations Ͼ30 pM, and significant induction of NO at the lowest concentration tested (2 pM).
but it is reasonable to assume that it is based on the Manα1-2Manα1-2Manα1-6Manα1-4GlcNα1-6PI strucIn contrast, the trypomastigote peak I material and all of the epimastigote materials were at least 100-fold less ture common to all T.cruzi GPI/GIPL structures thus far identified (De Lederkremer et al., 1991; Güther et al. , active in these assays. Although all of the data shown here were obtained using IFN-γ-primed macrophges, similar 1992; Couto et al., 1993; Previato et al., 1995; Serrano et al., 1995; Carreira et al., 1996) . Monosaccharide comresults were obtained using unprimed macrophages except that the levels of induction were lower, producing~40, position analysis by GC-MS revealed the presence of only mannose and galactose, in the ratio 4.0:2.5, suggesting 20 and 10% of the TNF-α, IL-12 and NO levels shown in Figures 1 and 2 .
that the trypomastigote GPI anchors are substituted with, on average, 2.5 galactose residues. It is worth noting that proteinase K, unlike Pronase
Purification and analysis of the mucin GPI anchors
In order to establish the structural basis for the bioactivity (Ferguson et al., 1988) , appears to be capable of cleaving between the C-terminal amino acid and the ethanolamine of the trypomastigote versus the epimastigote peak II mucins, these materials were digested with proteinase K, phosphate bridge. The removal of amino acids from the GPI anchors was not complete, and some molecular and the GPI anchors of each repurified by octyl-Sepharose chromatography. After pooling the myo-inositol-conspecies containing aspartic acid were observed in the mass spectra. Furthermore, amino acid sequencing of the GPI taining fractions, the purified GPI anchors were titrated for NO-and cytokine-inducing activity alongside the intact fraction revealed Asp and a trace of Ile-Asp. These observations are consistent with the predicted amino acid
The bioactive trypomastigote mucin GPI anchors are free from Mycoplasma lipopeptides sequences of the T.cruzi mucins, many of which contain a conserved IDGS sequence next to a C-terminal hydroMycoplasma lipopeptides are among the most potent known proinflammatory microbial products (Mühlradt phobic sequence (Salazar et al., 1996; Di Noia et al., 1998; Freitas-Junior et al., 1998 ), such that D would et al., 1997 . Since Mycoplasma are common tissue culture contaminants, it was important to exclude the be the predicted peptide cleavage/GPI attachment site (Udenfriend and Kodukula, 1995) .
possibility of Mycoplasma lipopeptide contamination from TOF-MS) analysis of 10 pmol of the GPI preparation did not reveal any peptides or lipopeptides under conditions where 10 pmol of a synthetic MALP-2 were clearly visible ( Figure 3 ).
Epimastigote GPI-mucins and GIPLs from different strains of T.cruzi are inactive and do not inhibit the activity of trypomastigote GPI-mucins
To investigate whether the lack of cytokine and NO induction by Y strain GPI-mucins and GIPLs was unique to this strain of T.cruzi, GPI-mucins and GIPLs were purified from CL and Tulahuen strains, and, together with Y strain materials, tested at concentrations up to 400 nM ( Figure 4A ). The chemical compositions of the epimastigote GIPLs and GPI-mucin GPI anchors (released by proteinase K) were analysed by ES-MS and ES-MS-CID-MS, as described above, and the data are summarized in Table II . The trypomastigote GPI-mucins produced maximal NO, TNF-α and IL-12 synthesis at the lowest concentration used in this experiment (3.3 nM), and some reduction in the synthesis of TNF-α and IL-12 was observed at 80 and 400 nM trypomastigote GPI-mucin. In contrast, the epimastigote materials showed little or no bioactivity across the whole concentration range. The ceramidecontaining GIPLs from Y, CL and Tulahuen strains were particularly inactive in all of the assays, as was the CL strain GPI-mucin containing an lyso-alkyl-PI moiety in the GPI anchor. Only the alkylacyl-PI-containing Y strain GPI-mucins and CL strain GIPLs showed significant activity: at 400 nM these materials produced~30% of the epimastigote GPI-mucins and GIPLs. Although some inhibition was observed at epimastigote GPI-mucin and GIPL concentrations of 16 nM and above (rising to a the bioactive T.cruzi GPI preparations. As mentioned above, Edman sequencing (five cycles) of the purified maximum of 30% inhibition at 400 nM), it seems unlikely that the lack of activity in the epimastigote GPI-mucins trypomastigote GPI preparation revealed only D and a trace of I in the first cycle, and only a trace of D in the and GIPLs is due to the presence of an inhibitory agent. second cycle, consistent with D and ID linked to the GPI ethanolamine phosphate bridge. No further residues were Discussion detected in the third, fourth and fifth cycles. In contrast, five cycles of Edman sequencing of synthetic Mycoplasma
The unsaturated fatty acid of the trypomastigote GPI alkylacyl-PI moiety is likely to be important for bioactivity fermentans lipopeptide (MALP-2) produced the expected XGNND sequence (Muhlradt et al., 1997) in good yield, since the trypomastigote peak I mucins, which appear to be identical to the peak II mucins except that they contain where X (an empty cycle) is due to the thioether glycerolipid-modified N-terminal cysteine residue. Other mainly lyso-alkyl-PI moieties (Table I) , are relatively inactive. This is also consistent with the known alkali proinflammatory Mycoplasma lipopeptides (e.g. those of M.hyorhinis) have N-terminal sequences of XGQTD or lability of the trypomastigote mucin bioactivity . The trypomastigote GPI PI moieties alone XGQTN (Muhlradt et al., 1998) . Thus, the lack of G in the second cycle and the lack of any residues in the third, (isolated after deamination of the trypomastigote peak II mucin) were inactive at concentrations up to 25 nM, fourth and fifth Edman cycles of the T.cruzi trypomastigote GPI fraction strongly suggested that the preparation was suggesting that other features of the intact GPI anchor are also necessary for bioactivity. Although it is possible that devoid of contaminating Mycoplasma lipopeptides.
Finally, positive-ion matrix-assisted laser desorption the differences in the carbohydrate structures of the epimastigote and trypomastigote GPIs are crucial for ionization time-of-flight mass spectrometry (MALDI-bioactivity, it is also conceivable that the precise structure of the GPI anchor glycan may not be critical and that it serves, in this context, to solubilize the unsaturated alkylacyl-PI moiety to make it available to its macrophage receptor. Despite considerable efforts, we were unable to confirm certain chemical (e.g. catalytic hydrogenation and mild acid hydrolysis) and enzymatic (e.g. α-and β-galactosidases) modifications to the trypomastigote GPI fraction by ES-MS. This was due to the small amounts of material available from trypomastigotes (Almeida et al., 1994) , which are non-dividing cells that are cultured by the infection of mammalian cell monolayers (Andrews and Colli, 1982) . In the absence of mass spectrometric confirmation of the predicted modifications to trypomastigote GPIs, the effects of these treatments on bioactivity are inadmissible. Therefore, in the long term, we plan to resolve the minimum structural features required for bioactivity by chemical synthesis.
An important feature of the data presented here is the extremely low concentration of the trypomastigote GPI anchors required for cytokine induction. Previous work using highly purified GPI material from T.brucei variant surface glycoproteins has shown cytokine induction at micromolar rather than sub-nanomolar concentrations (Magez et al., 1998) . Similarly, Schofield and colleagues have estimated that their P.falciparum and T.brucei GPI anchor preparations are active in the 0.1-10 μM range (Tachado and Schofield, 1994; Schofield et al., 1996; Tachado et al., 1996) . These low specific activities are similar to those observed here for the relatively inactive T.cruzi epimastigote GIPLs and epimastigote mucin GPI anchor structures, and one might question the physiological relevance of effects using micromolar concentrations of GPIs.
Dual requirements for the carbohydrate and lipid components have been proposed to account for cytokine induction by protozoal GPI anchors. Tachado et al. (1997) suggest a receptor for the GPI glycan and the translocation of the PI moiety to the cytoplasm to act as a second messenger, whereas Magez et al. (1998) suggest the involvement of two distinct receptors for the glycan and lipid components of T.brucei-derived GPI anchors. In contrast, we were unable to detect any cytokine or NO induction using the purified PI component of the trypomastigote GPI anchor, even when presented to macrophages at concentrations up to 25 nM (~1000-fold higher than that required for the induction of TNF-α and IL-12 (Table II) ; AAG, MAG and CER indicate the presence of mechanism by which trypomastigote mucins might reach alkylacylglycerol, monoalkylglycerol or ceramide lipids in the PI moieties of the GPI structures. Macrophages were primed with IFN-γ a putative macrophage receptor in vivo is unknown.
(100 U/ml) overnight and then stimulated with 3.3, 16, 80 and 400 nM However, the passive shedding from, and re-incorporation epimastigote-derived glycoconjugate. As a positive control, Y strain into, cell plasma membranes by GPI-anchored proteins is trypomastigote GPI-mucin was used at the same concentrations. a well known phenomenon, and mono-molecular, micellar and GIPLs. Titration of the inhibition of NO (top panels), TNF-α In conclusion, we have established that highly purified (middle panels) and IL-12(p40) (bottom panels) induction by 1 nM GPI anchors isolated from GPI-anchored mucins from one trypomastigote GPI-mucin by pre-incubation (2 h) with epimastigote GPI-mucins and GIPLs.
life cycle stage (trypomastigote) of T.cruzi, and having The GPI anchor was obtained after proteinase K digestion of the purified mucin as described in Materials and methods. b The most abundant GPI species within the mixture is underlined. c The monoalkyglycerol-PI species was obtained from alkylacylglycerol-PI (m/z 909 or 917) species after alkaline hydrolysis (6 M ammonium hydroxide, 37°C, 1 h), to remove the fatty acid at the sn-2 position of the glycerol, followed by purification on an octyl-Sepharose column. CER, ceramide; AAG, alkylacylglycerol; MAG, monoalkylglycerol.
unique structural features ( Figure 5 ), are extremely potent genesis of cardiac and/or oesophagus and/or colon pathology observed during chronic Chagas' disease. inducers of NO, IL-12 and TNF-α when presented to macrophages. On a molar basis, this material is at least as active as bacterial lipopolysaccharide (LPS) (Camargo et al., 1997a) and Mycoplasma lipopeptides (Mühlradt Animals et al., 1997 , establishing it as one of the most abolished its NO-inducing activity, as expected (Mühlradt (Camargo, 1964 (Camargo, ). et al., 1998 , but had no significant effect on the NOinducing activity of trypomastigote mucin (data not
Materials and methods

Purification of epimastigote and trypomastigote mucins shown).
Trypanosoma cruzi mucin-like glycoproteins from trypomastigote and epimastigote forms (Y strain) were purified using a slight modification Finally, it is possible that T.cruzi trypomastigote GPI of previous procedures (Almeida et al., 1994; Serrano et al., 1995) . In anchors may be crucial for the potentiation of innate brief, parasite pellets containing in total 1.5 ϫ 10 10 trypomastigotes and cellular immunity, which controls the parasite population infection (Aliberti et al., 1996; Fearon and Locksley, methanol (1:2, v/v); and (iv) chloroform:methanol:water (1:2:0.8, by 1996; Brener and Gazzinelli, 1997) . Moreover, despite the vol.). Between each extraction, insoluble cell debris was separated from controversy about the mechanism of immunopathogenesis the organic phase by centrifugation (1500 g, 15 min, 10°C). The final of Chagas' disease (Brener and Gazzinelli, 1997) , recent delipidated parasite debris was dried under N 2 and extracted three times with 10 vols of butan-1-ol-saturated water (9% butan-1-ol) (4 h, at room studies suggest that T.cruzi parasites are physically present temperature). The resulting extracts were combined, dried under vacuum, at the sites of inflammation (Higuchi et al., 1993; Jones dissolved in 5% propan-1-ol, 0.1 M ammonium acetate (buffer A), et al., 1993; Vago et al., 1996) . Thus, the local release and applied onto an octyl-Sepharose (Amersham-Pharmacia Biotech, of trypomastigote GPI-anchored mucins could play an Uppsala, Sweden) column (1.0 ϫ 10 cm) at a flow rate of 4 ml/h, at room temperature. After washing with 10 vols of buffer A and 10 vols important role in parasite-elicited inflammation and the SpeedVac, redissolved in 90 μl of 10 mM Tris-HCl pH 7.8, 1 mM CaCl 2 , and incubated with 10 μl of proteinase K (5 mg/ml; Promega, Madison, WI) for 16 h at 37°C. The incubation was terminated by heating at 100°C for 5 min. The sample was then extracted three times with 200 μl of water-saturated butan-1-ol (91% butan-1-ol). The released GPI moiety was recovered in the butanolic phases, which were combined and washed further (three times) with water to remove any residual glycopeptides and/or salts. The sample was purified further on an octylSepharose column as described above. Five microlitres of each 1 ml fraction were used for myo-inositol and ES-MS analyses.
Myo-inositol and monosaccharide analyses
Native mucins and isolated GPIs were quantified by their myo-inositol content using selective ion monitoring at m/z 305, 307, 318 and 321 of trimethylsilyl derivatives . Monosaccharides were quantified as methyl-glycoside-trimethylsilyl derivatives as decribed in , except that selected ion-monitoring GC-MS (for m/z 173, 204, 217, 272, 298, 305 and 318) was used.
Mass spectrometry of GPI fractions
Trypomastigote and epimastigote GPI samples (2.5 and 4.9 pmol/μl, respectively) were introduced into the Micromass Quattro electrospray source (Micromass, Manchester, UK) at 5 μl/min in 50% propan-1-ol, 0.2% formic acid. Negative ion spectra were collected. The capillary voltage was 2.3 kV, the cone voltage was 40 V and cone/skimmer offset was 5 V.
Positive-ion MALDI-TOF spectra of GPIs and synthetic MALP-2 lipopeptide were recorded in linear mode using a PerSeptive Biosystems Voyager DE-STR spectrometer and α-cyano-4-hydroxycinnamic acid as the matrix.
Preparation and analysis of PI components
Epimastigote and trypomastigote mucins (peaks I and II; 4.8 and 1.8 nmol with respect to myo-inositol content, respectively) were dissolved in 200 μl of water and extracted three times with 200 μl of butan-1-ol Fig. 5 . Comparison of active and representative relatively inactive saturated with water to remove any contaminating lipids. The aqueous T.cruzi GPI structures. The epimastigote mucin (peak II) GPI structure phases were dried and redissolved in 40 μl of 0.1 M sodium acetate (Previato et al., 1995; Serrano et al., 1995) is consistent with the buffer pH 4.0, and deaminated by three additions (at 1 h intervals) of ES-MS spectrum in Figure 2E and the ES-MS analysis of the PI 10 μl of 0.5 M sodium nitrite, at 60°C. The samples were mixed with moiety (Table I) . Only the identity and linkage position of the 250 μl of 9% butan-1-ol and the released PIs were recovered by three additional hexose residue (ϮHex) are unknown (Previato et al., 1995;  extractions with 250 μl of butan-1-ol saturated with water. The combined Serrano et al., 1995) . The proposed trypomastigote peak II GPI butanolic phases were dried, redissolved in 200 μl of chloroform:methstructure is based on the epimastigote structure and is consistent with anol:5 mM ammonium acetate (10:10:3, by vol.) and introduced into the ES-MS spectrum in Figure 2D , the GC-MS monosaccharide the electrospray source at 5 μl/min. Negative-ion spectra were collected. analysis and the ES-MS analysis of the PI moiety (Table I ). The
The capillary voltage was 2.5 kV, the cone voltage was 60 V and dotted line indicates that the linkage position(s) of the uncharacterized cone/skimmer offset was 5 V. Collision-induced dissociation (CID) galactose substituents (Gal 0-4 ) is unknown. The types and proportions experiments were performed using 2.5 ϫ 10 -3 torr argon and an acceleratof the major alkyl and acyl (fatty acid) chains are indicated. The exact ing voltage of 50 V. Epimastigote GIPLs (peak III; 5.6 nmol myo-inositol) isomer of the C18:2 fatty acid (shown here as linoleic acid) has not were also submitted (without pre-extraction with butan-1-ol) to nitrous been determined. The ceramide-containing epimastigote (peak III) deamination and PI analysis as described above. GIPL structure is taken from De Lederkremer et al. (1991) and Previato et al. (1990) , and is consistent with an ES-MS spectrum of N-acetylation this fraction (data not shown) and the ES-MS analysis of the PI Samples were N-acetylated at 0°C in 40 μl of 1 M ammonia by two moiety (Table I) .
additions of 1 μl of acetic anhydride, 10 min apart. After 30 min at room temperature, 160 μl of water were added and the samples were of 5% propan-1-ol, the column was eluted using a propan-1-ol gradient desalted by freeze-drying twice. (5-60%), at a flow rate of 12 ml/h. Eighty 1 ml fractions were collected. For detection of the trypomastigote mucin-containing fractions, 2-5 μl Macrophage culture aliquots of each fraction were used for Western blotting and chemi-C3H/HeJ mice were inoculated intraperitoneally with 2 ml of 3% luminescent-enzyme-linked immunosorbent assay (CL-ELISA) using thioglycollate. Four days later, the elicited peritoneal exudate cells were anti-α-galactosyl (anti-Gal) antibodies purified from chronic Chagas' harvested in cold FCS-free DMEM (Life Technologies, Grand Island, disease patients (Almeida et al., 1991 (Almeida et al., , 1994 . Epimastigote and trypo-NY) and centrifuged at 700 g for 10 min at 4°C. Cells were resuspended mastigote mucins were also detected by silver staining of the SDS-polyin DMEM supplemented with 5% heat-inactivated FCS, 2 mM acrylamide gel . GIPLs were identified by ES-MS L-glutamine and 40 μg/ml gentamicin sulfate (MacMed), at a final analysis (see below) of 5 μl aliquots of each octyl-Sepharose-purified concentration of 2 ϫ 10 6 /ml, and 0.1 ml aliquots were transferred into fraction. The alkylacylglycerol-and ceramide-containing GIPLs were wells of a 96-well plate. Cells were allowed to adhere at 37°C and 5% enriched in different fractions of peak III, with the former eluting slightly CO 2 for 3 h, and were then washed once with serum-free DMEM. One earlier than the latter. Note: the appearance of substantial amounts of hundred microlitres of MacMed were added to the macrophage cultures GIPLs in the 9% butan-1-ol fraction was a reproducible phenomenon in a final volume of 200 μl/well. Purified parasite preparations were that shows that the T.cruzi GIPLs (particularly the alkylacylglycerolincubated with macrophages in the presence or absence of IFN-γ containing species) are not extracted quantitatively into chloroform:
(100 U/ml; Genzyme Corp., Cambridge, MA). Aliquots of the supernatant methanol:water (1:2:0.8, by vol.). This is different from the situation in (50 and 100 μl) were collected after 24 and 48 h of culture for TNF-α other trypanosomatids, such as the Leishmania, and suggests that the and IL-10 as well as IL-12(p40) measurements, respectively (Camargo T.cruzi GIPLs and mucins may co-extract as a complex. et al., 1997a,b) .
Isolation of the epimastigote and trypomastigote mucin Cytokine and nitric oxide measurements GPIs
All samples were analysed in duplicate. TNF-α was quantified employing Briefly,~1 and 3 nmol (with respect to myo-inositol content) of trypomastigote and epimastigote mucins, respectively, were dried in a an ELISA kit (Genzyme, Duoset kit). IL-12(p40) was assayed by
